Skip to content

Clinical trials

Observational Angina, Stable trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angina, Stable Phase: Observational Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20041
20062
20072
20081
20092
20103
20111
20127
20133
20147
20158
20166
20178
20184
20194
20206
20219
20222
20235
20245
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Unknown status32
Recruiting12
Not yet recruiting7
Active, not recruiting4
Terminated2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London14
I.M. Sechenov First Moscow State Medical University3
Samsung Medical Center3
Taipei City Hospital3
Assiut University2
Biosensors Europe SA2
Central Clinical Hospital of the Russian Academy of Sciences2
Imperial College London2
Luzerner Kantonsspital2
Medhub Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angina, Stable102
Angina, Unstable34
Coronary Artery Disease30
Non-ST Elevated Myocardial Infarction20
Myocardial Infarction18
Angina Pectoris17
Heart Failure16
ST Elevation Myocardial Infarction16
Acute Coronary Syndrome14
Myocardial Ischemia11

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.